<- Go Home
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally.
Market Cap
$41.2B
Volume
4.6M
Cash and Equivalents
$3.7B
EBITDA
$2.1B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$4.8B
Profit Margin
76.60%
52 Week High
$96.12
52 Week Low
$58.93
Dividend
N/A
Price / Book Value
4.32
Price / Earnings
26.94
Price / Tangible Book Value
5.90
Enterprise Value
$37.5B
Enterprise Value / EBITDA
18.01
Operating Income
$1.9B
Return on Equity
19.14%
Return on Assets
10.65
Cash and Short Term Investments
$4.4B
Debt
$706.7M
Equity
$9.6B
Revenue
$6.3B
Unlevered FCF
$1.8B
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium